Management of high defibrillation threshold

References

• Birnie D, Tung S, Simpson C et al. Complications associated with defibrillation threshold testing: the Canadian experience. Heart Rhythm5(3), 387–390 (2008).
   PubMed Web of Science ®Google Scholar
• Russo AM, Sauer W, Gerstenfeld EP et al. Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion? Heart Rhythm2(5), 456–461 (2005).
   PubMedGoogle Scholar
• Strickberger SA, Klein, GJ. Is defibrillation testing required for defibrillator implantation? J. Am. Coll. Cardiol.44, 88–91 (2004).
   PubMedGoogle Scholar
• Schuger C, Ellenbogen KA, Faddis M, Knight BP, Yong P, Sample R. Defibrillation energy requirements in an ICD population receiving resynchronization therapy. J. Cardiovasc. Electrophysiol.17(3), 247–250 (2006).
   PubMedGoogle Scholar
• Theuns DA, Szili-Torok T, Jordaens LJ. Defibrillation efficacy testing: long-term follow-up and mortality. Europace7(6), 509–515 (2005).
   PubMedGoogle Scholar
• Rosenbeck S, Sharon Z, Weiss A. Long-term follow-up of patients with relatively high effective defibrillation threshold during cardioverter defibrillator implantation with endocardial leads. Cardiology112(2), 107–113 (2008).
   PubMedGoogle Scholar
• Sverdlow CD. Reappraisal of implant testing of implantable cardioverter defibrillators. J. Am. Coll. Cardiol.44, 92–94 (2004).
   PubMedGoogle Scholar
• Haissaguerre M, Shoda M, Jais P, Akihiko N et al. Mapping and ablation of idiopathic ventricular fibrillation. Circulation106, 962–967 (2002).
   PubMed Web of Science ®Google Scholar
• Nanthakumar K, Newman D, Paquitle M, Dorion P et al. Systemic evaluation of the determinants of defibrillation efficacy. Heart Rhythm2, 34–36 (2005).
   Google Scholar
• Swerdlow CD, Fan W, Brewer JE. Charge-burping theory correctly predicts optimal ratios of biphasic duration for biphasic defibrillation waveforms. Circulation94, 2278–2284 (1996).
   PubMedGoogle Scholar
• Russell AD, Chirammel U, Martin PT et al. Benefit of millisecond waveform durations for patients with high defibrillation thresholds. Heart Rhythm3, 536–542 (2006).
   PubMedGoogle Scholar
• Natarajan S, Henthorn R, Burroughs J et al. “Tuned” defibrillations waveforms outperform 50/50% tilt defibrillation waveforms: a randomized multi-center study. PACE30, 5139–5142 (2007).
   Google Scholar
• Kroll MW, Efimov IR, Tchou PJ. Present understanding of shock polarity for internal defibrillation: the obvious and non-obvious clinical implications. PACE29, 885–891 (2006).
   Google Scholar
• Cohen TJ, Lowenkron DD. The effects of pneumothorax on defibrillation thresholds during pectoral implantation of an active can implantable cardioverter defibrillator. Pacing Clin. Electrophysiol.21(2), 468–470 (1998).
   PubMed Web of Science ®Google Scholar
• Luria D, Stanton MS, Eldar M, Glikson M. Pneumothorax: an unusual cause of ICD defibrillation failure. Pacing Clin. Electrophysiol.21(2), 474–475 (1998).
   PubMed Web of Science ®Google Scholar
• Gold M, Val-Mejias J, Leman RB et al. Optimization of superior vena cava coil position and usage for transvenous defibrillation. Heart Rhythm5(3), 394–399 (2008).
   PubMedGoogle Scholar
• Rashba EJ, Bonner M, Wilson J, Shorofsky SR, Peters RW, Gold MR. Distal right ventricular coil position reduces defibrillation thresholds. J. Cardiovasc. Electrophysiol.14(10), 1036–1040 (2003).
   PubMedGoogle Scholar
• Lubinski A, Lewicka-Nowak E, Królak T et al. Implantation and follow-up of ICD leads implanted in the right ventricular outflow tract. Pacing Clin. Electrophysiol.23(11 Pt 2), 1996–1998 (2000).
   PubMedGoogle Scholar
• Roberts PR, Allen S, Betts T et al. Increased defibrillation threshold with right-sided active pectoral can. J. Interv. Card. Electrophysiol.4(1), 245–249 (2000).
   PubMed Web of Science ®Google Scholar
• Wetherbee JN, Chapman PD, Troup PJ et al. Long-term internal cardiac defibrillation threshold stability. Pacing Clin. Electrophysiol.12, 443–450 (1989).
   PubMedGoogle Scholar
• Kirk MM, Shorofsky SR, Khalighi K et al. Chronic rise in monophasic defibrillation thresholds with a transvenous lead system. Am. J. Cardiol.79, 502–505 (1997).
   PubMedGoogle Scholar
• Vendetti FJ, Martin DT, Vassolas G, Bowen S. Rise in chronic defibrillation thresholds in nonthoracotomy implantable defibrillator. Circulation89, 216–223 (1994).
   PubMedGoogle Scholar
• Hsia HH, Mitra RL, Flores BT, Marchlinski FE. Early postoperative increase in defibrillation threshold with non-thoracotomy system in humans. Pacing Clin. Electrophysiol.17, 1166–73 (1994).
   PubMed Web of Science ®Google Scholar
• Poole JE, Bardy GH, Dolack GL, Kudenchuk PJ, Anderson J, Johnson G. Serial defibrillation threshold measures in man: a prospective controlled study. J. Cardiovasc. Electrophysiol.6, 19–25 (1995).
   PubMedGoogle Scholar
• Tummala RV, Riggio DR, Peters RW et al. Chronic rise in defibrillation threshold with a hybrid lead system. Am. J. Cardiol.78, 309–312 (1996).
   PubMedGoogle Scholar
• Tokano T, Pelosi F, Flemming M et al. Long-term evaluation of the defibrillation energy requirement. J. Cardiovasc. Electrophysiol.9, 916–920 (1998).
   PubMedGoogle Scholar
• Martin DT, John R, Venditti FJ. Increase in defibrillation threshold in non-thoracotomy implantable defibrillators using a biphasic waveform. Am. J. Cardiol.76, 263–266 (1995).
   PubMedGoogle Scholar
• Schwartzman D, Callans DJ, Gottlieb CD et al. Early postoperative rise in defibrillation threshold in patients with non-thoracotomy defibrillation lead systems: attenuation with biphasic shock waveforms. J. Cardiovasc. Electrophysiol.7, 483–493 (1996).
   PubMedGoogle Scholar
• Haffajee C, Martin D, Bhandari A et al. A multicenter, randomized trial comparing an active can implantable defibrillator with a passive can system. Pacing Clin. Electrophysiol.20, 215–219 (1997).
   PubMedGoogle Scholar
• Gold MR, Foster AH, Shorofsky SR. Effects of an active pectoral pulse generator shell on defibrillation efficacy with a transvenous lead system. Am. J. Cardiol.78, 540–543 (1996).
   PubMedGoogle Scholar
• Bardy GH, Johnson G, Poole JE et al. A simplified, single-lead unipolar transvenous cardioversion-defibrillation system. Circulation88, 543–547 (1993).
   PubMedGoogle Scholar
• Saksena S, the PCD Investigators. Defibrillation thresholds and perioperative mortality associated with endocardial and epicardial defibrillation lead systems. PACE16, 202–207 (1993).
   Google Scholar
• Kleman JM, Castle LW, Kidwell GA et al. Nonthoracotomy- versus thoracotomy-implantable defibrillators. Intention-to-treat comparison of clinical outcomes. Circulation90, 2833–2842 (1994).
   PubMedGoogle Scholar
• Zipes DP, Roberts D. Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. Circulation92, 59–65 (1995).
   PubMedGoogle Scholar
• Gold MR, Shorofsky SR. Transvenous defibrillation lead systems. J. Cardiovasc. Electrophysiol.7, 570–580 (1996).
   PubMedGoogle Scholar
• Frame R, Brodman R, Furman S et al. Long-term stability of defibrillation thresholds with intrapericardial defibrillator patches. Pacing Clin. Electrophysiol.16, 208–212 (1993).
   PubMedGoogle Scholar
• Guarnieri T, Levine JH, Veltri EP et al. Success of chronic defibrillation and the role of anti-arrhythmic drugs with the automatic implantable cardioverter-defibrillator. Am. J. Cardiol.60, 1061–1064 (1987).
   PubMedGoogle Scholar
• Gold MR, Kavesh NG, Peters RW et al. Biphasic waveforms prevent the late rise of defibrillation thresholds with a transvenous lead system. J. Am. Coll. Cardiol.30, 233–236 (1997).
   PubMedGoogle Scholar
• Rashba EJ, Olsovsky MR, Shorofsky SR et al. Temporal decline in defibrillation thresholds with an active pectoral lead system. J. Am. Coll. Cardiol.38, 1150 (2001).
   PubMedGoogle Scholar
• Gold MR, Higgins S, Klein R et al. Efficacy and temporal stability of reduced safety margins for ventricular defibrillation: primary results from the Low Energy Safety Study (LESS). Circulation105(17), 2043–2048 (2002).
   PubMedGoogle Scholar
• Kerber RE, Martins JB, Kienzle MG et al. Energy, current, and success in defibrillation and cardioversion: clinical studies using an automated impedance-based method of energy adjustment. Circulation77, 1038–1046 (1988).
   PubMed Web of Science ®Google Scholar
• Lerman BB, DiMarco JP, Haines DE. Current-based versus energy based defibrillation: a prospective study. J. Am. Coll. Cardiol.12, 1259–1264 (1988).
   PubMedGoogle Scholar
• Kroll M, Brewer J, Ellenbogen K. Upward DFT shift as a cause of sudden death. Presented at: The XIIth World Congress on Cardiac Pacing & Electrophysiology. Hong Kong, PR China, 19–22 February 2003.
   Google Scholar
• Strickberger SA, Hummel JD, Horwood LE et al. Effect of shock polarity on ventricular defibrillation threshold using a transvenous lead system. J. Am. Coll. Cardiol.24, 1069–1072 (1994).
   PubMedGoogle Scholar
• Thakur RK, Souza JJ, Chapman PD et al. Electrode polarity is an important determinant of defibrillation efficacy using a nonthoracotomy system. PACE17, 919–923 (1994).
   Google Scholar
• Schauerte P, Stellbrink C, Schondube FA et al. Polarity reversal improves defibrillation efficacy in patients undergoing tranvenous cardioverter defibrillator implantation with biphasic shocks. PACE20, 301–306 (1997).
   Google Scholar
• Shorofsky SR, Gold MR. Effects of waveform and polarity on defibrillation thresholds in humans using a transvenous lead system. Am. J. Cardiol.78, 313–316 (1996).
   PubMedGoogle Scholar
• Natale A, Sra J, Dhala A et al. Effects of initial polarity on defibrillation threshold with biphasic pulses. PACE18, 1889–1893 (1995).
   Google Scholar
• Strickberger SA, Man KC, Daoud E et al. Effect of first phase polarity of biphasic shocks on defibrillation threshold with a single transvenous lead system. J. Am. Coll. Cardiol.25, 1605–1608 (1995).
   PubMedGoogle Scholar
• Keelan ET, Sra JS, Axtell K et al. The effect of polarity of the initial phase of a biphasic shock waveform on the defibrillation threshold of pectorally implanted defibrillators. PACE20, 337–342 (1997).
   Google Scholar
• Swartz JF, Fletcher RD, Karasik PE. Optimization of biphasic waveforms for human nonthoracotomy defibrillation. Circulation88, 2646–2654 (1993).
   PubMed Web of Science ®Google Scholar
• Natale A, Sra j, Krum D et al. Relative efficacy of different tilts with biphasic defibrillation in humans. PACE19, 197–206 (1996).
   Google Scholar
• Sweeney MO, Natale A, Volosin KJ et al. Prospective randomized comparison of 50%/50% versus 65%/65% tilt biphasic waveform on defibrillation in humans. PACE24, 60–65 (2001).
   Google Scholar
• Denman RA, Umesan C, Martin PT et al. Benefit of millisecond waveform durations for patients with high defibrillation thresholds. Heart Rhythm3, 536–541 (2006).
   PubMedGoogle Scholar
• Bardy GH, Dolack GL, Kudenchuk PJ et al. Prospective, randomized comparison in humans of a unipolar defibrillation system with that using an additional superior vena cava electrode. Circulation89, 1090–1093 (1994).
   PubMedGoogle Scholar
• Gold MR, Foster AH, Shorofsky SR. Lead system optimization for transvenous defibrillation. Am. J. Cardiol.80, 1163–1167 (1997).
   PubMedGoogle Scholar
• Gold MR, Olsovsky MR, Pelini MA et al. Comparison of single- and dual-coil active pectoral defibrillation lead systems. J. Am. Coll. Cardiol.31, 1391–1394 (1998).
   PubMedGoogle Scholar
• Mann DE, Klein RC, Higgins SL et al. LESS Investigators: The Low Energy Safety Study (LESS): rationale, design, patient characteristics, and device utilization. Am. Heart J.143, 199–204 (2002).
   PubMedGoogle Scholar
• Cesario D, Bhargava M, Valderrabano M et al. Azygos vein lead implantation: a novel adjunctive technique for implantable cardioverter defibrillator placement. J. Cardiovasc. Electrophysiol.15, 780–783 (2004).
   PubMedGoogle Scholar
• Stajdhar KC, Ott GY, Kron J et al. Optimal electrode position for transvenous defibrillation: a prospective randomized study. J. Am. Coll. Cardiol.27, 90–94 (1996).
   PubMedGoogle Scholar
• Butter C, Meisel E, Tebbenjohanns J et al. Transvenous biventricular defibrillation halves energy requirements in patients. Circulation104, 2533–2538 (2001).
   PubMedGoogle Scholar
• Epstein AE, Ellenbogen KA, Kirk KA et al. Clinical characteristics and outcome of patients with high defibrillation thresholds: a multi-center study. Circulation86, 1206–1216 (1992).
   PubMedGoogle Scholar
• Page RL. Effects of antiarrhythmic medication on implantable cardioverter-defibrillator function. Am. J. Cardiol.85, 1481–1485 (2000).
   PubMedGoogle Scholar
• Jones DL, Kim YH, Natale A, Klein GJ, Varin F. Bretylium decreases and verapamil increases defibrillation threshold in pigs. Pacing Clin. Electrophysiol.17(8), 1380–1390 (1994).
   PubMedGoogle Scholar
• Fain ES, Lee JT, Winkle RA. Effects of acute intravenous and chronic oral amiodarone on defibrillation energy requirements. Am. Heart J.114(1 Pt 1), 8–17 (1987).
   PubMedGoogle Scholar
• Pelos F Jr, Oral H, Kim MH et al. Effect of chronic amiodarone therapy on defibrillation energy requirements in humans. J. Cardiovasc. Electrophysiol.11(7), 736–740 (2000).
   PubMedGoogle Scholar
• Hohnoser SH, Dorian P, Roberts R et al. Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial. Circulation114(2), 104–109 (2006).
   PubMedGoogle Scholar
• Dorian P, Newman D, Sheahan R, Tang A, Green M, Mitchell J. d-sotalol decreases defibrillation energy requirements in humans: a novel indication for drug therapy. J. Cardiovasc. Electrophysiol.7(10), 952–961 (1996).
   PubMedGoogle Scholar
• Marinchak RA, Friehling TD, Kline RA, Stohler J, Kowey PR. Effect of antiarrhythmic drugs on defibrillation threshold: case report of an adverse effect of mexiletine and review of the literature. Pacing Clin. Electrophysiol.11(1), 7–12 (1988).
   PubMedGoogle Scholar
• Crystal E, Ovsyshcher IE, Wagshal AB, Katz A, Ilia R. Mexiletine related chronic defibrillation threshold elevation: case report and review of the literature. Pacing Clin. Electrophysiol.25(4 Pt 1), 507–508 (2002).
   PubMedGoogle Scholar
• Shinlapawittayatorn K, Sungnoon R, Chattipakorn S, Chattipakorn N. Effects of sildenafil citrate on defibrillation efficacy. J. Cardiovasc. Electrophysiol.17(3), 292–295 (2006).
   PubMedGoogle Scholar
• Deeb GM, Hardesty RL, Griffith BP, Thompson ME, Heilman MS, Myerowitz RL. The effects of cardiovascular drugs on the defibrillation threshold and the pathological effects on the heart using an automatic implantable defibrillatior. Ann. Thorac. Surg.35(4), 361–366 (1983).
   PubMedGoogle Scholar
• McBride BF, White CM, Kalus JS et al. The impact of carvedilol on the defibrillation threshold. Heart Lung37(1), 67–71 (2008).
   PubMedGoogle Scholar
• Kamochi H, Yamanouchi Y, Saku K. Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on ventricular defibrillation threshold. Pacing Clin. Electrophysiol.29(7), 747–752 (2006).
   PubMedGoogle Scholar
• Kloner RA. Cardiovascular risk and sildenafil. Am. J. Cardiol.86, 57F–61F (2000).
   PubMed Web of Science ®Google Scholar
• Shinlpawittayatorn K, Sungnoon R, Chattipakorn S, Chattipakorn N. Effects of sildenafil citrate on defibrillation efficacy. J. Cardiovasc. Electrophysiol.17(3), 292–295 (2006).
   PubMedGoogle Scholar
• Weinroum AA, Glick A, Copperman Y, Yashar T, Rudick V, Flaishon R. Halothane, isoflurane, and fentanyl increase the minimally effective defibrillation threshold of an implantable cardioverter defibrillator: first report in humans. Anesth. Analg.95(5), 1147–1153 (2002).
   PubMedGoogle Scholar
• Kim H, Jones DL, Natale A, Klein GJ. Ethanol increases defibrillation threshold in pigs. Pacing Clin. Electrophysiol.16(1 Pt 1), 19–25 (1993).
   PubMedGoogle Scholar
• Papaioannou GI and Kluger J. Ineffective ICD therapy due to excessive alcohol and exercise. Pacing Clin. Electrophysiol.25(7), 1144–1145 (2002).
   PubMedGoogle Scholar
• Kalus JS, White CM, Caron MF, Guertin D, McBride BF, Kluger J. The impact of catecholamines on defibrillation threshold in patients with implanted cardioverter defibrillators. Pacing Clin. Electrophysiol.28(11), 1147–1156 (2005).
   PubMedGoogle Scholar